HER2-Targeted Radioimmunotherapy Yields Complete and Lasting Remission in Breast Cancer Model
A groundbreaking development in the treatment of HER2-positive breast cancer has emerged, heralding a new era in radioimmunotherapy that promises both efficacy and safety. Published...
















